XML 26 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Dec. 31, 2022
OPERATING ACTIVITIES      
Net income $ 100,190 $ 259,485 $ 373,306
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation 68,325 71,634 65,011
Amortization of intangibles 62,127 65,794 55,695
Impairment charges 93,515 4,853 4,546
Deferred revenue (2,028) 1,787 115
Non-cash inventory charges 0 0 15,593
Stock-based compensation 26,012 23,898 23,626
(Gain) loss on investments and other assets (112) 291 14,024
Deferred income taxes (2,823) 46 (22,419)
Other (7,873) 5,473 32,680
Changes in operating assets and liabilities:      
Trade receivables (15,347) 24,517 (19,334)
Inventories 47,143 82,471 (89,235)
Accounts payable 16,260 (36,277) (22,403)
Accrued liabilities and income taxes (34,560) (61,022) (9,495)
Prepaid expenses and other assets 16,792 14,437 (1,992)
Net cash provided by operating activities 367,621 457,387 419,718
INVESTING ACTIVITIES      
Acquisitions of businesses, net of cash acquired 0 (198,810) (532,670)
Purchases of property, plant, and equipment (75,877) (86,188) (104,341)
Net proceeds from sale of property, plant, and equipment 10,836 832 676
Other (741) (151) (62)
Net cash used in investing activities (65,782) (284,317) (636,397)
FINANCING ACTIVITIES      
Proceeds of term loan 0 0 300,000
Proceeds from senior notes payable 0 0 100,000
Payments of senior notes payable 0 (121,302) (25,000)
Repayments of other debts (2,707) (2,697) (1,552)
Payments of term loan (7,500) (7,500) (3,750)
Net proceeds (payments) related to stock-based award activities 5,694 7,934 (862)
Debt issuance costs 0 0 (2,723)
Cash dividends paid (67,061) (62,161) (55,911)
Purchases of common stock (40,862) 0 0
Net cash (used in) provided by financing activities (112,436) (185,726) 310,202
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (20,089) 4,840 (11,420)
Increase (decrease) in cash, cash equivalents, and restricted cash 169,314 (7,816) 82,103
Cash, cash equivalents, and restricted cash at beginning of period 557,123 564,939 482,836
Cash, cash equivalents, and restricted cash at end of period 726,437 557,123 564,939
Reconciliation of cash and cash equivalents:      
Cash and cash equivalents 724,924 555,513 562,588
Restricted cash included in prepaid expenses and other current assets 0 0 802
Restricted cash included in other long-term assets 1,513 1,610 1,549
Cash paid during the period for interest 36,207 37,167 25,439
Cash paid during the period for income taxes, net of refunds 83,765 73,932 93,622
Capital expenditures, not yet paid $ 11,727 $ 9,191 $ 11,725